Article info

Download PDFPDF
Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors

Authors

  1. Correspondence to Dr Jonathan R Kerr, Department of Microbiology, West Suffolk Hospitals NHS Trust, Bury Saint Edmunds, Suffolk IP33 2QZ, UK; jonathan{at}ssl-mail.com
View Full Text

Citation

Kerr JR
Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors

Publication history

  • Received March 3, 2019
  • Revised May 19, 2019
  • Accepted June 10, 2019
  • First published July 17, 2019.
Online issue publication 
September 21, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.